Updated : Wed, October 1, 2014 @ 4:43 PM
Originally Published : Thu, Aug 05, 2010 @ 08:07 AM
Biosearch Technologies today announces the company has licensed exclusively from the University of Medicine and Dentistry of New Jersey (UMDNJ) a Single Molecule Fluorescent in-situ hybridization technology based on detection of RNA. Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits into the Research, Applied Markets and IVD fields under the UMDNJ technologies and patent applications.
To read the entire story, read the full press release.